Vaccine

pass the torch deal sell buy acquisition
Biotech

GSK offloads shigella vaccine to Bharat ahead of phase 3

GSK framed the deal as a way to get the vaccine to patients in low- and middle-income countries where the pathogen is a health threat.
Nick Paul Taylor Jun 12, 2025 9:18am
Messenger RNA

Arcturus doubles down on mRNA, axes several early-stage assets

May 13, 2025 1:32pm
Space shuttle takes off on background of blue sky

Manufacturer Emergent invests in next-gen vax biotech

Mar 12, 2025 10:22am
packing boxes moving layoffs failure shut down

GSK to move vaccine R&D group from Maryland to Massachusetts

Feb 12, 2025 11:27am
Squirting gel onto hand from container

Harmless skin bacteria engineered to be living topical vaccine

Dec 11, 2024 11:00am
computer generated 3D illustration of a clostridium difficile bacterium

mRNA vaccine protects mice from deadly C. diff infections

Oct 4, 2024 1:08pm